Heragen, Inc. is developing a novel genomic based Breast Cancer Recurrence Test. Heragen, Inc. will help physicians and oncologists make educated decisions using a patented technology. Heragen, Inc. is a spin-off from the Breast Cancer Startup Challenge conducted by National Institute of Health (NIH), National Cancer Institute (NCI), Avon Foundation and Center for Advanced Innovation (CAI).
| Website | http://www.heragen.com |
| Employees | View employees |
| Founded | 2014 |
| Technologies |
JavaScript
,
HTML
,
PHP
+29 more
(view full list)
|
| Industry | Biotechnology Research |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Heragen employee's phone or email?
The NAICS codes for Heragen are [541, 5417, 541711, 54171, 54].